Kerry 9 Month Revenues up 10.9% to €4.4bn, Confident On Targets
date:Nov 01, 2012
launches and broader beverage applications.

In line with the Groups objective to prioritise growth in developing markets, significant resources and expertise are being deployed to support Kerrys strategic development and customer growth objectives in such fast growing markets. The Groups Pharma platform will also be further extended in line with global market requirements with significant investment in science and RD capability which will be leveraged globally.

Against a backdrop of compet
12/18 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/25 23:23